Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v85-v99.
Authors: A. M. Vannucchi, T. Barbui, F. Cervantes, C. Harrison, J.-J. Kiladjian, N. Kröger, J. Thiele and C. Buske
Philadelphia chromosome negative chronic myeloproliferative neoplasms include polycythaemia vera, essential thrombocythaemia and primary myelofibrosis. The new ESMO Clinical Practice Guidelines provide the latest information on the treatment of myeloproliferative neoplasms including recommendations for achieving an accurate diagnosis, assessing prognosis and management and follow-up strategies associated with distinct subtypes.